QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.049346v1 306/2/455    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pol, O. Articles by Puig, M. M. Search for Related Content PubMed PubMed Citation Articles by Pol, O. Articles by Puig, M. M.

INFLAMMATION AND IMMUNOPHARMACOLOGY

The Expression of - and -Opioid Receptor Is Enhanced during Intestinal Inflammation in Mice

Department of Anesthesiology, Institut Municipal Investigació Mèdica, Hospital Universitario del Mar, Universistat Autònoma de Barcelona, Barcelona, Spain (O.P., M.M.P.); and Department of Immunology, Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Barcelona, Spain (J.R.P.)

In the gut, µ-, -, and -opioid receptors are present in the submucous and myenteric plexi and in enterocytes. Using pharmacological methods, our group has shown that intestinal inflammation enhances the antitransit and antisecretory effects of systemic opioids. The aim of the present study was to evaluate whether the enhanced antisecretory effects of and -agonists were associated with an increased transcription and/or expression of these receptors at central (brain and spinal cord) and/or peripheral sites (gut); we also evaluated the expression of - and -opioid receptors in dissected sections of the gut containing the myenteric (MP/LM) or submucous (SP/M) plexi. The mRNA and protein levels of both opioid receptors were determined using a reverse-transcriptase polymerase chain reaction and immunoprecipitation/Western blot, respectively. Intestinal inflammation significantly augmented the transcription of -opioid receptors in the spinal cord (34%) and in the whole gut (102%). Also increased mRNA and protein levels of -opioid receptors in the MP/LM and SP/M preparations. The -opioid receptors gene transcription was not altered by inflammation, whereas -opioid receptors protein levels were significantly enhanced in the SP/M preparation. No changes in gene transcription or protein levels for - and -opioid receptors could be demonstrated in the brain. These results suggest that local transcriptional and post-transcriptional changes of the - and -opioid receptors genes could be responsible for the enhanced antisecretory effects of - and -opioid agonists during intestinal inflammation.

Address correspondence to: Dr. Olga Pol, Anesthesiology Research Unit, Institut Municipal Investigació Mèdica, Doctor Aiguader, 80, 08003 Barcelona, Spain. E-mail: opol{at}imim.es

This article has been cited by other articles:

				K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821. [Abstract] [Full Text] [PDF]

				N. Jimenez, M. M. Puig, and O. Pol Antiexudative Effects of Opioids and Expression of {kappa}- and {delta}- Opioid Receptors during Intestinal Inflammation in Mice: Involvement of Nitric Oxide J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 261 - 270. [Abstract] [Full Text] [PDF]

				C. Borner, J. Kraus, H. Schroder, H. Ammer, and V. Hollt Transcriptional Regulation of the Human {micro}-Opioid Receptor Gene by Interleukin-6 Mol. Pharmacol., December 1, 2004; 66(6): 1719 - 1726. [Abstract] [Full Text] [PDF]